Centene Corp. Hits New 52-Week High of $62.09, Signaling Recovery

Centene Corp., a prominent player in the healthcare services industry, has reached a significant milestone by hitting a new 52-week high of USD 62.09 on June 1, 2026. This achievement marks a notable recovery for the stock, which has experienced a one-year performance decline of 11.23%, contrasting sharply with the S&P 500's impressive gain of 28.56% during the same period. With a market capitalization of USD 17,692 million, Centene operates within the mid-cap segment of the market. The company's price-to-earnings (P/E) ratio stands at 27.00, indicating its valuation relative to earnings. Additionally, Centene's price-to-book ratio is 0.89, suggesting that the stock may be trading below its book value. Despite a dividend yield of 0.00% and a debt-to-equity ratio of -0.14, Centene's return on equity is recorded at 3.30%. The stock's previous 52-week low was USD 25.08, highlighting the significant upward movement it has achieved in recent trading sessions. This new high reflects the company's ongoing developments and market dynamics within the healthcare sector.